Literature DB >> 1304906

Equilibrium denaturation studies of mouse beta-nerve growth factor.

D E Timm1, K E Neet.   

Abstract

Equilibrium denaturation of dimeric mouse beta-nerve growth factor (beta-NGF) has been studied by monitoring changes in the protein's spectroscopic characteristics. Denaturation of beta-NGF in guanidine hydrochloride and urea resulted in an altered intrinsic fluorescence emission spectrum, fluorescence depolarization, and diminished negative circular dichroism. Native-like spectroscopic properties and specific biological activity are restored when denaturant is diluted from unfolded samples, demonstrating that this process is fully reversible. However, refolding of denatured beta-NGF is dependent on the three disulfide bonds present in the native protein and does not readily occur when the disulfide bonds are reduced. Graphical analysis and nonlinear least-squares fitting of beta-NGF denaturation data demonstrate that denaturation is dependent on the concentration of beta-NGF and is consistent with a two-state model involving native dimer and denatured monomer (N2 = 2D). The conformational stability of mouse beta-NGF calculated according to this model is 19.3 +/- 1.1 kcal/mol in 100 mM sodium phosphate at pH 7. Increasing the hydrogen ion concentration resulted in a 25% decrease in beta-NGF stability at pH 4 relative to pH 7.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1304906      PMCID: PMC2142196          DOI: 10.1002/pro.5560010205

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  27 in total

1.  Molecular cloning and expression of brain-derived neurotrophic factor.

Authors:  J Leibrock; F Lottspeich; A Hohn; M Hofer; B Hengerer; P Masiakowski; H Thoenen; Y A Barde
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

2.  Determination and analysis of urea and guanidine hydrochloride denaturation curves.

Authors:  C N Pace
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  Amino acid sequences of mouse 2.5S nerve growth factor. II. Isolation and characterization of the thermolytic and peptic peptides and the complete covalent structure.

Authors:  R H Angeletti; M A Hermodson; R A Bradshaw
Journal:  Biochemistry       Date:  1973-01-02       Impact factor: 3.162

4.  Topography of mouse 2.5S nerve growth factor. Reactivity of tyrosine and tryptophan.

Authors:  W A Frazier; R A Hogue-Angeletti; R Sherman; R A Bradshaw
Journal:  Biochemistry       Date:  1973-08-14       Impact factor: 3.162

5.  Amino acid sequences of mouse 2.5S nerve growth factor. I. Isolation and characterization of the soluble tryptic and chymotryptic peptides.

Authors:  R H Angeletti; D Mercanti; R A Bradshaw
Journal:  Biochemistry       Date:  1973-01-02       Impact factor: 3.162

6.  Multiple forms of the nerve growth factor protein and its subunits.

Authors:  A P Smith; S Varon; E M Shooter
Journal:  Biochemistry       Date:  1968-09       Impact factor: 3.162

Review 7.  Circular dichroism and its empirical application to biopolymers.

Authors:  W C Johnson
Journal:  Methods Biochem Anal       Date:  1985

8.  The role of the tryptophan residues in the activity of the nerve growth factor.

Authors:  R H Angeletti
Journal:  Biochim Biophys Acta       Date:  1970-09-29

9.  Beta nerve growth factor binding to PC12 cells. Association kinetics and cooperative interactions.

Authors:  N R Woodruff; K E Neet
Journal:  Biochemistry       Date:  1986-12-02       Impact factor: 3.162

10.  Conformational stability and mechanism of folding of ribonuclease T1.

Authors:  J A Thomson; B A Shirley; G R Grimsley; C N Pace
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

View more
  13 in total

1.  A common mechanism for recombinant human NGF, BDNF, NT-3, and murine NGF slow unfolding.

Authors:  L R De Young; C H Schmelzer; L E Burton
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Folding is coupled to dimerization of Tctex-1 dynein light chain.

Authors:  Matthew Talbott; Michael Hare; Afua Nyarko; Thomas S Hays; Elisar Barbar
Journal:  Biochemistry       Date:  2006-06-06       Impact factor: 3.162

3.  Unfolding and refolding of dimeric creatine kinase equilibrium and kinetic studies.

Authors:  Y X Fan; J M Zhou; H Kihara; C L Tsou
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

4.  Mutational studies of conserved residues in the dimer interface of nerve growth factor.

Authors:  M Guo; S L Meyer; H Kaur; J J Gao; K E Neet
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

5.  Characterization of the recombinant extracellular domain of the neurotrophin receptor TrkA and its interaction with nerve growth factor (NGF).

Authors:  S B Woo; C Whalen; K E Neet
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

6.  Conformational stability of pGEX-expressed Schistosoma japonicum glutathione S-transferase: a detoxification enzyme and fusion-protein affinity tag.

Authors:  W Kaplan; P Hüsler; H Klump; J Erhardt; N Sluis-Cremer; H Dirr
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

7.  The pro-peptide of proNGF: structure formation and intramolecular association with NGF.

Authors:  Marco Kliemannel; Ralph Golbik; Rainer Rudolph; Elisabeth Schwarz; Hauke Lilie
Journal:  Protein Sci       Date:  2007-01-22       Impact factor: 6.725

8.  The use of fluorescence methods to monitor unfolding transitions in proteins.

Authors:  M R Eftink
Journal:  Biophys J       Date:  1994-02       Impact factor: 4.033

9.  Denaturation of an extremely stable hyperthermophilic protein occurs via a dimeric intermediate.

Authors:  Sara Lawrence Powers; Clifford R Robinson; Anne Skaja Robinson
Journal:  Extremophiles       Date:  2006-10-28       Impact factor: 2.395

10.  RhNGF slow unfolding is not due to proline isomerization: possibility of a cystine knot loop-threading mechanism.

Authors:  L R De Young; L E Burton; J Liu; M F Powell; C H Schmelzer; N J Skelton
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.